Annual report pursuant to Section 13 and 15(d)

Stockholders??? Equity (Details) - Schedule of Assumptions used to Determine the Fair Value of Options Granted

v3.23.3
Stockholders’ Equity (Details) - Schedule of Assumptions used to Determine the Fair Value of Options Granted - $ / shares
 12 Months Ended
Jul. 31, 2023
Jul. 31, 2022
Stockholders’ Equity (Details) - Schedule of Assumptions used to Determine the Fair Value of Options Granted [Line Items]    
Options Granted 640,000 1,858,250
Exercise Price Range $ 2.01 $ 2.88
Term (years) 5 years 5 years
Vesting Period (years) 3 years 3 years
FMV of options Granted/Per Share $ 1.03 $ 1.52
Expected Life (years) 3 years 6 months 3 years 6 months
Minimum [Member]    
Stockholders’ Equity (Details) - Schedule of Assumptions used to Determine the Fair Value of Options Granted [Line Items]    
Exercise Price Range $ 1.97 $ 2.21
FMV of options Granted/Per Share $ 1.07 $ 1.17
Expected Volatility % 73.44% 73.25%
Interest Rate % 3.03% 1.73%
Maximum [Member]    
Stockholders’ Equity (Details) - Schedule of Assumptions used to Determine the Fair Value of Options Granted [Line Items]    
Exercise Price Range $ 2.42 $ 3.64
FMV of options Granted/Per Share $ 1.28 $ 1.78
Expected Volatility % 73.77% 74.52%
Interest Rate % 4.10% 3.03%